124 related articles for article (PubMed ID: 10425277)
1. Clinical implications of telomerase activity in resected hepatocellular carcinoma.
Kanamaru T; Yamamoto M; Morita Y; Itoh T; Kuroda Y; Hisatomi H
Int J Mol Med; 1999 Sep; 4(3):267-71. PubMed ID: 10425277
[TBL] [Abstract][Full Text] [Related]
2. Telomerase as a tool for the differential diagnosis of human hepatocellular carcinoma.
Nouso K; Urabe Y; Higashi T; Nakatsukasa H; Hino N; Ashida K; Kinugasa N; Yoshida K; Uematsu S; Tsuji T
Cancer; 1996 Jul; 78(2):232-36. PubMed ID: 8673997
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of telomerase activity in hepatocellular carcinoma.
Ohta K; Kanamaru T; Yamamoto M; Saitoh Y
Kobe J Med Sci; 1996 Jun; 42(3):207-17. PubMed ID: 8973088
[TBL] [Abstract][Full Text] [Related]
4. [Telomerase activity in liver cancer and the adjacent tissue].
Fu J; Zhang W; Jin S
Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):434-6. PubMed ID: 10920937
[TBL] [Abstract][Full Text] [Related]
5. Immuno-histochemical detection of human telomerase reverse transcriptase in human liver tissues.
Kawakami Y; Kitamoto M; Nakanishi T; Yasui W; Tahara E; Nakayama J; Ishikawa F; Tahara H; Ide T; Kajiyama G
Oncogene; 2000 Aug; 19(34):3888-93. PubMed ID: 10951582
[TBL] [Abstract][Full Text] [Related]
6. Thymidine phosphorylase activity in liver tissue and its correlation with multifocal occurrence of hepatocellular carcinomas.
Ikeguchi M; Sakatani T; Ueda T; Hirooka Y; Kaibara N
In Vivo; 2001; 15(4):265-70. PubMed ID: 11695216
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma.
Yao DF; Wu XH; Zhu Y; Shi GS; Dong ZZ; Yao DB; Wu W; Qiu LW; Meng XY
Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):220-6. PubMed ID: 15908319
[TBL] [Abstract][Full Text] [Related]
8. Des-gamma-carboxy prothrombin in cancer and non-cancer liver tissue of patients with hepatocellular carcinoma.
Tang W; Miki K; Kokudo N; Sugawara Y; Imamura H; Minagawa M; Yuan LW; Ohnishi S; Makuuchi M
Int J Oncol; 2003 May; 22(5):969-75. PubMed ID: 12684661
[TBL] [Abstract][Full Text] [Related]
9. Surgical significance of telomerase activity in noncancerous liver tissue from patients with hepatocellular carcinoma.
Kanamaru T; Morita Y; Itoh T; Yamamoto M; Kuroda Y; Hisatomi H
Jpn J Cancer Res; 1998 Jul; 89(7):727-32. PubMed ID: 9738979
[TBL] [Abstract][Full Text] [Related]
10. Telomerase in hepatocellular carcinogenesis.
Ide T; Tahara H; Nakashio R; Kitamoto M; Nakanishi T; Kajiyama G
Hum Cell; 1996 Dec; 9(4):283-6. PubMed ID: 9183659
[TBL] [Abstract][Full Text] [Related]
11. Involvement of RhoA in progression of human hepatocellular carcinoma.
Wang D; Dou K; Xiang H; Song Z; Zhao Q; Chen Y; Li Y
J Gastroenterol Hepatol; 2007 Nov; 22(11):1916-20. PubMed ID: 17914970
[TBL] [Abstract][Full Text] [Related]
12. Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status.
Saini N; Srinivasan R; Chawla Y; Sharma S; Chakraborti A; Rajwanshi A
Liver Int; 2009 Sep; 29(8):1162-70. PubMed ID: 19627485
[TBL] [Abstract][Full Text] [Related]
13. Telomerase activity and telomerase catalytic subunit in hepatocellular carcinoma.
Lee CM; Hsu CY; Eng HL; Huang WS; Lu SN; Changchien CS; Chen CL; Cho CL
Hepatogastroenterology; 2004; 51(57):796-800. PubMed ID: 15143919
[TBL] [Abstract][Full Text] [Related]
14. Abnormal expression of hepatomas and circulating telomerase and its clinical values.
Wu W; Yao DF; Qiu LW; Wu XH; Yao M; Su XQ; Zou L
Hepatobiliary Pancreat Dis Int; 2005 Nov; 4(4):544-9. PubMed ID: 16286259
[TBL] [Abstract][Full Text] [Related]
15. [Usefulness of telomerase activity in the diagnosis of small hepatocellular carcinoma].
Higashi T; Nouso K; Tsuji T
Nihon Rinsho; 1998 May; 56(5):1248-52. PubMed ID: 9613132
[TBL] [Abstract][Full Text] [Related]
16. Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas.
Tahara H; Nakanishi T; Kitamoto M; Nakashio R; Shay JW; Tahara E; Kajiyama G; Ide T
Cancer Res; 1995 Jul; 55(13):2734-6. PubMed ID: 7796395
[TBL] [Abstract][Full Text] [Related]
17. [Telomere length and telomerase activity in hepatocellular carcinoma].
Nakashio R; Kitamoto M; Nakanishi T; Takaishi H; Takahashi S; Kajiyama G
Nihon Rinsho; 1998 May; 56(5):1239-43. PubMed ID: 9613130
[TBL] [Abstract][Full Text] [Related]
18. The role of telomerase activity in hepatocellular carcinoma.
Shimada M; Hasegawa H; Gion T; Utsunomiya T; Shirabe K; Takenaka K; Otsuka T; Maehara Y; Sugimachi K
Am J Gastroenterol; 2000 Mar; 95(3):748-52. PubMed ID: 10710069
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis and in situ localization of human telomerase RNA in chronic liver disease and hepatocellular carcinoma.
Ogami M; Ikura Y; Nishiguchi S; Kuroki T; Ueda M; Sakurai M
Lab Invest; 1999 Jan; 79(1):15-26. PubMed ID: 9952107
[TBL] [Abstract][Full Text] [Related]
20. Telomerase reverse transcriptase gene amplification in hepatocellular carcinoma.
Takuma Y; Nouso K; Kobayashi Y; Nakamura S; Tanaka H; Matsumoto E; Fujikawa T; Suzuki M; Hanafusa T; Shiratori Y
J Gastroenterol Hepatol; 2004 Nov; 19(11):1300-4. PubMed ID: 15482538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
